Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of April 6th – 12th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
10. Champignon Brands to Acquire Health Canada Licensed Psychedelic Clinic Operator AltMed
AltMed Owns 75% of a Fully Operational Ketamine Clinic Located Near Toronto, Ontario
Champignon Brands (cse:SHRM) /zigman2/quotes/217267142/composite SHRMF -8.37% (fra:496) announced it has entered into a definitive agreement to acquire 100% of AltMed Capital Corp. AltMed is a preeminent Canadian Ketamine clinic operator, psychedelic medicine IP aggregator and novel drug discoverer. AltMed’s Psychedelics clinic is licensed by Health Canada to dose eligible patients with Psilocybin and is the only clinic in Canada able to perform Psilocybin doses under Health Canada approval.
READ FULL CHAMPIGNON BRANDS ARTICLE
9. Horizons Completes Quarterly Rebalance of its Cannabis ETFs, Here Are Both ETFs Top 10 Holdings Now
Horizon’s 2 Cannabis ETFs Attempt to Mimic the Performance of the North American Marijuana Index and the U.S. Marijuana Companies Index
Horizons ETFs Management (Canada) recently completed the quarterly rebalance of its cannabis-focused ETFs Horizons Marijuana Life Sciences Index ETF /zigman2/quotes/208856346/delayed CA:HMMJ -4.50% and Horizons U.S. Marijuana Index ETF (neo:HMUS). Following the rebalance, here’s what the two Cannabis ETFs look like now.
READ FULL CANNABIS ETFS ARTICLE
8. These Companies Plan to Use Psychedelic Medicine to End the Opioid Epidemic Once and For All
The Opioid Crisis Has Plagued America for Decades, According to the HHS, it Kills an Estimated 130+ People Per Day
Thanks to recent advancements in psychedelic medicine, there’s renewed hope and optimism surrounding the deadly opioid epidemic. ATAI Life Sciences, DemeRx and MindMed (neo:MMED) (fra:BGHM) are waging war against opioid addiction By utilizing this one little-known Psychedelic substance.
READ FULL OPIOID EPIDEMIC ARTICLE
7. Canntrust Confirms Delisting From NYSE, TSX
The Delisting, Which Was Previously Anticipated After the Company Obtained Creditor Protection, is Now Official
It seems that it’s all over for CannTrust Holdings shareholders. The company confirmed within a news release that its equity will be delisted from the major exchanges, and that a cease trade order will remain on the equity.
READ FULL CANNTRUST ARTICLE
6. Trulieve Reports Record Q4 Revenue, Reaffirms 2020 Guidance Despite COVID-19 Pandemic